Wu Tsung-Han, Wang Yu-Chao, Hung Hao-Chien, Lee Jin-Chiao, Wu Chia-Ying, Cheng Chih-Hsien, Lee Chen-Fang, Wu Ting-Jung, Chou Hong-Shiue, Chan Kun-Ming, Lee Wei-Chen
Department of General Surgery and Chang Gung Transplantation Institute, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.
Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.
J Pers Med. 2022 Jan 9;12(1):79. doi: 10.3390/jpm12010079.
Hepatocellular carcinoma (HCC) occurring at the left lateral segment (LLS) is relatively susceptible to treatment with curative intent in terms of tumor location. However, outcomes might vary depending on the selection of treatment modalities. This study aimed to analyze patients who had undergone curative treatment for early HCC at LLS.
A retrospective analysis of 179 patients who underwent curative treatment for early HCC at LLS was performed. Patients were grouped based on treatment modalities, including radiofrequency ablation (RFA) and liver resection (LR). The long-term outcomes of the two groups were compared. Additionally, the impact of the LR approach on patient outcomes was analyzed.
Among these patients, 60 received RFA and 119 underwent LR as primary treatment with curative intent. During follow-up, a significantly higher incidence of HCC recurrence was observed in the RFA group (37/60, 61.7%) than in the LR group (45/119, 37.8%) ( = 0.0025). The median time of HCC recurrence was 10.8 (range: 1.1-60.9 months) and 17.6 (range: 2.4-94.8 months) months in the RFA and LR groups, respectively. In addition, multivariate analysis showed that liver cirrhosis, multiple tumors, and RFA treatment were significant risk factors for HCC recurrence. The 1-, 2-, and 5-year overall survival rates in the RFA and LR groups were 96.4%, 92.2%, and 71.5% versus 97.3%, 93.6%, and 87.7%, respectively. ( = 0.047). Moreover, outcomes related to LR were comparable between laparoscopic and conventional open methods. The 1-, 2-, and 5-year recurrence free survival rates in the laparoscopic ( = 37) and conventional open ( = 82) LR groups were 94.1%, 82.0%, and 66.9% versus 86.1%, 74.6%, and 53.1%, respectively. ( = 0.506) Conclusion: Early HCC at LLS had satisfactory outcomes after curative treatment, in which LR seems to have a superior outcome, as compared to RFA treatment. Moreover, laparoscopic LR could be considered a preferential option in the era of minimally invasive surgery.
就肿瘤位置而言,发生在左外叶(LLS)的肝细胞癌(HCC)相对易于接受根治性治疗。然而,治疗效果可能因治疗方式的选择而异。本研究旨在分析接受LLS早期HCC根治性治疗的患者情况。
对179例接受LLS早期HCC根治性治疗的患者进行回顾性分析。根据治疗方式将患者分组,包括射频消融(RFA)和肝切除术(LR)。比较两组的长期治疗效果。此外,分析了LR手术方式对患者治疗效果的影响。
在这些患者中,60例接受了RFA治疗,119例接受了LR作为根治性的初始治疗。随访期间,RFA组(37/60,61.7%)的HCC复发率显著高于LR组(45/119,37.8%)(P = 0.0025)。RFA组和LR组HCC复发的中位时间分别为10.8(范围:1.1 - 60.9个月)和17.6(范围:2.4 - 94.8个月)个月。此外,多因素分析显示肝硬化、多发肿瘤和RFA治疗是HCC复发的重要危险因素。RFA组和LR组的1年、2年和5年总生存率分别为96.4%、92.2%和71.5%,以及97.3%、93.6%和87.7%(P = 0.047)。此外,腹腔镜手术和传统开放手术的LR治疗效果相当。腹腔镜LR组(n = 37)和传统开放LR组(n = 82)的1年、2年和5年无复发生存率分别为94.1%、82.0%和66.9%,以及86.1%、74.6%和53.1%(P = 0.506)。结论:LLS早期HCC根治性治疗后预后良好,其中LR似乎比RFA治疗效果更佳。此外,在微创手术时代,腹腔镜LR可被视为优先选择。